Suddenly, Genomics: The edge of what we know, the ledge on which we stand, a conversation with Ting Wu
Tuesday, October 22, 2019 - 1:00pm to Tuesday, October 22, 2019 - 2:30pm

The availability of genetic testing as a means to provide critical information to researchers, medical professionals, and the public has become routine over the past decades. With the emergence of companies like 23andMe, individual consumers are now able to access their own genetic codes, gaining a better understanding of who they are and whether they are susceptible to genetic diseases. New technologies, such as CRISPR, meanwhile, enable scientists to edit genomes and have the potential for wide-ranging applications from human health to food production and beyond. As these technologies advance, researchers, regulators, and the public will face the task of determining how to best put them to use. Please join Dr. Ting Wu for a conversation about the potential benefits, as well as the ethical, legal, and social implications of personal genetics.

Ting Wu
Professor of Genetics at Harvard Medical School,
Director of the Consortium for Space Genetics,
Director of the Personal Genetics Education Project
When: Tuesday, October 22, 2019, 1:00-2:30pm
Where: Smith Memorial Student Union, Room 294
Light refreshments served
This event is limited to 30 participants. Please RSVP at:

About Ting Wu
Ting Wu is a Professor of Genetics at Harvard Medical School, Director of the Consortium for Space Genetics, and Director of the Personal Genetics Education Project (pgEd). She is the recipient of an NIH Director’s 2012 Pioneer Award for her laboratory’s work on genome organization, homolog pairing, and inheritance, and an NIH Director’s 2016 Transformative Research Award for work on sequence ultraconservation as a strategy for maintaining genome integrity. She is also a co-investigator on a Center of Excellence Award. As part of these efforts, her group has developed a variety of technologies, ranging from strategies that facilitate genome engineering to those that enable high-throughput screening of entire genomes using fluorescent in situ hybridization (Hi-FISH). She and her co-workers also invented the Oligopaints method for in situ visualization of DNA and RNA, including distinguishing maternal from paternal homologs using homolog-specific Oligopaints (HOPs). Most recently, her group has enabled in situ single-molecule super-resolution imaging of the genome via OligoSTORM and OligoDNA-PAINT, which reflect the combination of Oligopaints with the STORM (in collaboration with Xiaowei Zhuang) and DNA-PAINT (in collaboration with Ralf Jungmann and Peng Yin) technologies, respectively.

The Wu laboratory also houses pgEd, a nonprofit program which promotes public awareness and dialogue about genetics and genetic technologies across all communities through Congressional briefings, curricula and trainings for teachers, consultations with the film and television industry and, most recently, partnerships with communities of faith.

Wu received her B.A. from Harvard University in Biology and her Ph.D. from Harvard Medical School in Genetics. She briefly spent time at Stanford Medical School before completing her postdoctoral work at the Station for Natural Studies and Yale University. Wu was a fellow at the Massachusetts General Hospital in the Department of Molecular Biology from 1987 to 1991, then moved to Harvard Medical School’s main campus as an assistant professor, first in the Department of Anatomy and Cellular Biology and then in the Department of Genetics (1993). In 2005, she left the Department of Genetics to become a professor of pediatrics in the Division of Molecular Medicine at Boston Children’s Hospital. She returned to the Department of Genetics at Harvard Medical School as a full professor in 2007.

Dr. Wu will also be giving the 2019 Saward Lecture on Tuesday, Oct. 22, 2019 at the Newmark Theater.

Both events are sponsored by:

Kaiser Permanente: Center for Health Research